Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidence of Cancer
4.2.2 Rising Awareness on Radiotherapy
4.2.3 Increasing Public and Private Funding in Cancer Research
4.3 Market Restraints
4.3.1 Availability of Alternate Treatment Options
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Metal-Based Markers
5.1.2 Polymer-Based Markers
5.1.3 Others
5.2 By Modality
5.2.1 MRI
5.2.2 CT/CBCT
5.2.3 Ultrasound
5.2.4 X-Ray
5.3 By Application
5.3.1 Lung Cancer
5.3.2 Breast Cancer
5.3.3 Prostate Cancer
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of World


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 IZI Medical Products
6.1.2 CIVCO Radiotherapy
6.1.3 Gold Anchor (Naslund Medical AB)
6.1.4 Medtronic
6.1.5 QLRAD
6.1.6 Boston Scientific Corporation
6.1.7 Stellar Medical
6.1.8 Qfix
6.1.9 Nanovi A/S


7 MARKET OPPORTUNITIES AND FUTURE TRENDS